EUDA Health Holdings Ltd (EUDA)
EUDA Health Holdings Ltd is a Singapore-headquartered healthcare company listed on NASDAQ as common stock under the ticker EUDA. The company focuses on non-invasive healthcare services, with operations primarily in Singapore, Malaysia, and China. Its service and product offerings include bioenergy capsule services, stem cell therapy, CRISPR gene editing treatment services, and supplements. In addition to healthcare-related activities, EUDA also provides property management services. The business is organized as a public company rather than a fund or a specialty security, and its listing reflects ordinary common equity in the issuer.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-EUDA
|
$22.97
|
30.4% Upside
|
Undervalued
|
$55
|
212.1% Upside
|
Bargain
|
Fair
|
0.0%
|
7.7x
|
52.76 M
|
54.804 M
|
4.4%
|
58.8%
|
-139.1
|
90.3%
|
